# Smoking Cessation & Opioid Dependence Treatment Integration

> **NCT02854800** · PHASE2,PHASE3 · COMPLETED · sponsor: **West Virginia University** · enrollment: 74 (actual)

## Conditions studied

- Smoking Cessation
- Opioid Related Disorders

## Interventions

- **DRUG:** varenicline

## Key facts

- **NCT ID:** NCT02854800
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-08
- **Primary completion:** 2017-04-10
- **Final completion:** 2017-04-10
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854800, "Smoking Cessation & Opioid Dependence Treatment Integration". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02854800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
